Latest Contracts News

Mayne Pharma has announced the expiration of the US antitrust waiting period, a critical step forward in Cosette Pharmaceuticals' proposed acquisition. The transaction now moves closer to completion, pending other regulatory and shareholder approvals.

SciDev Limited reported a robust Q3 FY25 with revenue rising 10% and EBITDA tripling, driven by strategic US market expansion and a landmark PFAS remediation contract despite ongoing market challenges.

Althea Group Holdings has agreed to sell its pharmaceutical assets to Tasmanian Botanics, enabling a strategic pivot towards the booming North American THC-infused beverage market.

Westpac Banking Corporation reported a 9% decline in net profit for the first half of 2025, reflecting margin compression and higher costs, while advancing its digital transformation and sustainability agenda.

Boss Energy reports a successful ramp-up to commercial production at its Honeymoon uranium mine, backed by a robust $229 million cash position and promising growth at its US Alta Mesa project.

Kelsian Group signals a cautious FY25 outlook with EBITDA tracking at the lower end of guidance, while advancing strategic tourism divestments and securing key contract renewals.

Latrobe Magnesium Limited has successfully closed an oversubscribed Share Purchase Plan, raising $836,800 to fund its Demonstration Plant operations in Victoria. This capital injection supports the company’s pioneering sustainable magnesium extraction efforts.

First Graphene has secured a multi-year exclusive deal to supply graphene-enhanced masterbatch for safety boots aimed at Southeast Asia’s mining sector, marking a significant step in commercialising advanced materials in industrial apparel.

AUB Group Limited has upgraded its FY25 underlying net profit guidance to the upper end of its previously announced range, buoyed by favourable trading conditions and strategic FX hedging.

Nuix Limited has withdrawn its FY25 growth targets due to unpredictable timing in closing large deals, despite maintaining a strong pipeline and confidence in its strategic direction.

Eden Innovations’ US subsidiary has secured its first EdenCrete®Pz7 order from Holcim Mexico, marking the product’s expansion to three countries within the Holcim Group’s concrete operations.

BrainChip Holdings Ltd’s 2025 AGM reveals a strengthened product roadmap, breakthrough Edge AI technology advances, and a surge in commercial partnerships, positioning the company for accelerated growth.